DrugBank Online is a comprehensive, free-to-access, online database containing information on drugs and drug targets. As both a bioinformatics and a cheminformatics resource, we combine detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information. DrugBank Online is widely used by the drug industry, medicinal chemists, pharmacists, physicians, students and the general public. Because of its broad scope, comprehensive referencing, and detailed data descriptions, DrugBank is enabling major advancements across the data-driven medicine industry.
DrugBank Online is offered to the public as a free-to-access resource. Use and re-distribution of the content of DrugBank Online or the DrugBank Data, in whole or in part, for any purpose requires a license. Academic users may apply for a free license for certain use cases and all other users require a paid license.
To learn more about our solutions, please reach out to us using our contact form.
We ask that users who make use of DrugBank Online or DrugBank Data as part or your research cite the DrugBank manuscript in any resulting publications.
DrugBank started in 2006 in Dr. David Wishart’s lab at the University of Alberta. It began as a project to help academic researchers get detailed structured information about drugs. In 2011 it became a part of The Metabolomics Innovation Center (TMIC). The project continued to grow in scope and popularity and was spun out into OMx Personal Health Analytics Inc in 2015.
The original DrugBank project was funded by the the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with funding from the federal government. Learn more about TMIC here.
We’re very grateful to the funders and organizations that have supported DrugBank and helped bring it to life and continue to grow!
The latest release of DrugBank Online (version 5.1.8, released 2021-01-03) contains 14,589 drug entries including 2,714 approved small molecule drugs, 1,506 approved biologics (proteins, peptides, vaccines, and allergenics), 132 nutraceuticals and over 6,655 experimental (discovery-phase) drugs. Additionally, 5,263 non-redundant protein (i.e. drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Each entry contains more than 200 data fields with half of the information being devoted to drug/chemical data and the other half devoted to drug target or protein data.